2024 annual financial data
Adial Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -8,284,457 USD and net income was -13,197,451 USD.
Operating cash flow was -6,922,306 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,284,457 USD
- Net income
- -13,197,451 USD
- Operating cash flow
- -6,922,306 USD